Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
Improving antitumor efficacy of chimeric antigen receptor-engineered immune cell therapy with synthetic biology and combination therapy approaches
PDF
Novel design and combinatory therapy to enhance chimeric antigen receptor engineered T cells (CAR-T) efficacy against solid tumor
PDF
Generation and characterization of fully human anti-CD19 chimeric antigen receptor T (CAR-T) cells for the treatment of hematologic malignancies
PDF
Engineering chimeric antigen receptor (CAR) -modified T cells for enhanced cancer immunotherapy
PDF
Generation and characterization of humanized anti-CD19 chimeric antigen receptor T (CAR-T) cells for the treatment of hematologic malignancies
PDF
Engineering therapeutics for the improved antitumor efficacy of chimeric antigen receptor T cell therapy
PDF
Generation and characterization of anti-CD138 chimeric antigen receptor T (CAR-T) cells for the treatment of hematologic malignancies
PDF
Tumor necrosis therapy–interleukin-12 fusion proteins and cancer therapy
PDF
The role of CD99 in T cells
PDF
Enhancing chimeric antigen receptor-engineered immune cell therapy with synthetic biology and nanomedicine
PDF
Dendritic cell-specific vaccine utilizing antibody-mimetic ligand and lentivector system
PDF
Optimization of nanomedicine based drug delivery systems for the treatment of solid tumors
PDF
Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma
PDF
Oncolytic adenovirus based vaccine in cancer immunotherapy
PDF
Role of integrin α4 in drug resistant acute lymphoblastic leukemia
PDF
Characterization of epithelial-mesenchymal transition in acute myeloid leukemia
PDF
Dissertation_Xiaolu_Han 20170416 final draft
PDF
PDF
PDF
PDF
PDF
PDF
PDF
PDF
PDF